Development aspects of intellectual property rights on genetic resources: - extracts from the report by Catherine GREZE (Greens/EFA, FR)(recorded on Monday 14/01) - extracts from the vote

Type: News   Reference: 90136   Duration: 00:02:24  Lieu: Strasbourg, France - European Parliament
End production: 15/01/2013   First transmission: 15/01/2013
Pharmaceutical companies regularly draw on traditional knowledge to identify plants or substances with medicinal properties. Companies can patent the composition and process that arise from the research and development inspired by traditional knowledge. Often the local communities that called attention to the plants' useful properties do not benefit from this and in some cases it can even make it difficult for them to make use of their own discoveries. The problem is not only confined to the medical sector. It can also apply to firms developing new varieties of fruit and vegetables. There are concerns that biopiracy could impede developing countries' economic progress.Current legislation favours companies while traditional knowledge is offered little protection.

Only the original language version is authentic and it prevails in the event of its differing from the translated versions.
PDF version

TIME DESCRIPTION DURATION
00:00:00 Title 00:00:05
00:00:05 Exterior view of the EP, Strasbourg 00:00:05
00:00:10 SOUNDBITE (French) Catherine GREZE (Greens/EFA, FR): "In terms of development policies we need to reaffirm our will to eradicate bio piracy . we want to defend indigenous communities and cultures, local economies to respect the rights of small land holders to safeguard our environment and biodiversity". 00:00:27
00:00:37 SOUNDBITE (French) Catherine GREZE (Greens/EFA, FR): "The genetic resources are of crucial importance for sustainable agriculture and for food security all over the world". 00:00:12
00:00:49 SOUNDBITE (English ) Maroš ŠEFČOVIČ Vice-President EU Commissioner for Inter-Institutional Relations and Administration: "The impressive development of modern bio-science and the rapid growth of scientific research on genetic base of live have creating growing exportation of commercial value of biodiversity . it is now recognized that research and innovation related to biotechnology plays a significant role for the development and also can help the fight against poverty. however we have also withes the increasing concerns from developing countries related to misappropriation of genetic resources and on how to share the benefits staining from international property rights based on genetic resources from biodiversity from rich development countries". 00:00:43
00:01:32 SOUNDBITE (English ) Maroš ŠEFČOVIČ Vice-President EU Commissioner for Inter-Institutional Relations and Administration: "The new Treaty under the convention and biological diversity the Nagoya protocol on access to genetic resources and the fair and equitable sharing of benefits arising from the utilization - with the international community finally managed to negotiated in 2010 - should insure legal certainty for users of genetic resources and improves transparency on translation of that". 00:00:25
00:01:57 Views during the vote (3 shots) Cutaway with the rapporteur Catherine GREZE 00:00:17
00:02:14 Applause, adopted 00:00:10
00:02:24 END 00:00:00
Audiovisual Services
European Commission
ec.europa.eu/avservices
 
Conditions of use
© European Union, 2014